Ken Fisher Natera, Inc. Transaction History

Fisher Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$30.32 - $91.33 $13.8 Million - $41.6 Million	-455,473 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$86.26 - $119.0 $10.9 Million - $15 Million	126,257 Added 38.35%	455,473 $42.5 Million
Q3 2021 Oct 26, 2021	BUY	$100.17 - $126.36 $12.6 Million - $15.9 Million	125,782 Added 61.83%	329,216 $36.7 Million
Q2 2021 Jul 27, 2021	BUY	$86.05 - $119.72 $17.5 Million - $24.4 Million	203,434 New	203,434 $23.1 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.